Cite Filings / IRD / 0001974078-26-000396
Feed Companies Filings Check
Sign in
144

Sale of Securities

Opus Genetics, Inc. · Filed 2026-11-03 · Acc 0001974078-26-000396

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-11-05 4 Chief Executive Officer sold 28,258 shares at $3.90 ($110,184)
  • 2026-11-03 144 Sale of Securities
  • 2026-10-27 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-10-27 4 President sold 33,189 shares at an average $3.54 ($117,365)
  • 2026-10-27 4 Chief Financial Officer sold 14,000 shares at $3.55 ($49,650)
  • 2026-10-27 4 Chief Executive Officer sold 9,591 shares at $3.59 ($34,384)
  • 2026-10-23 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…